Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ARMCX1
REST API REST API
Homo sapiens
ARMCX1 is differentially expressed in 236 experiments: 115 organism parts: bone marrow, uterus, ... (113 more);, 219 disease states: normal, colon carcinoma, ... (217 more);, 75 cell types 465 cell lines 22 compound treatments and 69 other conditions.
Synonyms ALEX1
Orthologs Armcx1 (Mus musculus)   Q17QN5_BOVIN (Bos taurus)   ENSGALG00000008288 (Gallus gallus)   ARMC10 (Danio rerio)   Armcx1 (Rattus norvegicus)   armc10 (Xenopus laevis)   ARMCX1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term protein binding, membrane, integral to membrane, binding
InterPro Term Armadillo, DUF634
UniProt Accession Q68D26, Q9P291
Search EB-eye ENSG00000126947
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-6573, E-MEXP-1251, E-MTAB-24, E-MEXP-433, ... (19 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, E-GEOD-2450, ... (33 experiments)

Factor Value U/D Experiments
HL-60
3
E-GEOD-5258, E-GEOD-24147, E-MTAB-37
MCF-7
2
E-GEOD-20081, E-GEOD-19639
MOLT4
2
E-MTAB-62, E-MTAB-37
PC3
2
E-GEOD-5258, E-MEXP-2034
BT474
1
2
E-MTAB-37, E-MEXP-440, E-MTAB-62
CMA-01
1
E-MTAB-62
459 more value(s).


Cell type

studied in E-TABM-40, E-GEOD-21668, E-GEOD-3920, E-MEXP-66, E-GEOD-13909, ... (45 experiments)

Factor Value U/D Experiments
dendritic cell
2
E-MEXP-2019, E-GEOD-3982
stromal cell
1
2
E-GEOD-1460, E-MEXP-2034, E-GEOD-10797
monocyte
1
2
E-GEOD-11755, E-GEOD-5099, E-GEOD-8286
ADC
1
E-GEOD-19188
CD8+CD28+
1
E-MEXP-2345
CD8+CD28-
1
E-MEXP-2345
69 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-1869, E-GEOD-5563, E-TABM-15, E-GEOD-22148, ... (48 experiments)

Factor Value U/D Experiments
acute promyelocytic leukemia
3
E-GEOD-1729, E-MTAB-62, E-GEOD-995
colon carcinoma
1
3
E-MTAB-37, E-MTAB-62, E-GEOD-3726, E-MTAB-57
acute lymphoblastic leukemia
2
E-MTAB-62, E-MTAB-37
benign prostatic hyperplasia
2
E-MEXP-2034, E-MEXP-1243
lung adenocarcinoma
2
E-MTAB-37, E-MTAB-62
prostate carcinoma
2
E-MEXP-2034, E-MTAB-62
213 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-5741, E-TABM-782, E-GEOD-5824, E-GEOD-15811, ... (16 experiments)

Factor Value U/D Experiments
none
3
4
E-GEOD-20719, E-MEXP-1958, E-GEOD-4600, E-GEOD-5099, E-TABM-782, ... (7 experiments)
TGF-Beta1
1
E-MEXP-2645
MIG control
1
E-GEOD-15811
interferon-gamma + lipopolysaccharide
1
E-GEOD-5099
Cxcl12
1
E-GEOD-7307
phorbol 12-myristate 13-acetate
1
E-GEOD-4600
16 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
E-GEOD-19519
DMSO
1
E-GEOD-19519


Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd1a
studied in E-GEOD-22601

cd3
studied in E-GEOD-22601

cd34
studied in E-GEOD-22601

cd4
studied in E-GEOD-22601

cd8
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125, E-GEOD-1729

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-TABM-36, ... (11 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MTAB-62

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-21138

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-21589, E-GEOD-16363

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-7578, E-GEOD-20847, E-MTAB-108, ... (7 experiments)

Genotype
studied in E-GEOD-3494, E-GEOD-17476, E-MEXP-421, E-GEOD-22593, E-MEXP-1648, ... (9 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-5681, E-GEOD-7011, E-GEOD-12773, ... (10 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Her2 status
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-16194, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-176, E-MEXP-1956, E-MEXP-2069, ... (22 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-MEXP-561

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Lymph node status
studied in E-GEOD-22541, E-GEOD-6532

Material type
studied in E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Phenotype
studied in E-GEOD-26495, E-GEOD-21750, E-GEOD-1460, E-GEOD-17636, E-GEOD-4600 ... (5 experiments)

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-22097

pt
studied in E-GEOD-21653

Qpcr egfr dct
studied in E-GEOD-5851

RNAi
studied in E-MEXP-101, E-GEOD-3697, E-MEXP-1315, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-8052, E-GEOD-7307

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-11886

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-GEOD-16837, E-MEXP-973, E-GEOD-19246, ... (6 experiments)

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-3494, E-GEOD-1561, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.373 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM